Nontraumatic chylothorax and previous cancer: a role for positron emission tomography?

Garcia-Zamalloa A.

Source: Eur Respir J 2005; 26: 749-750
Journal Issue: October

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Garcia-Zamalloa A.. Nontraumatic chylothorax and previous cancer: a role for positron emission tomography?. Eur Respir J 2005; 26: 749-750

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001

The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004

Does positron emission tomography (PET/CT) have a role to play in the management of patients presenting with pleural changes suggestive of malignancy
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Year: 2009


Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009



Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008

Imaging the inflammatory activity of sarcoidosis
Source: Eur Respir J 2013; 41: 743-751
Year: 2013



Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET)
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001

Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer
Year: 2008


Rebuttal
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005

Advances in chest imagery
Source: Annual Congress 2006 - Clinical year in review
Year: 2006


Positron emission tomography findings in round atelectasis
Source: Annual Congress 2009 - Old and new: technique and pathology
Year: 2009

Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010



Imaging in lung cancer: positron emission tomography scan
Source: Eur Respir J 2002; 19: 49S-60S
Year: 2002



(18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Assessing nodules detected in lung cancer screening: the value of positron emission tomography
Source: Eur Respir J 2015; 45: 314-316
Year: 2015


Primary pulmonary artery sarcomas: improvement of preoperative diagnostic by positron emission tomography
Source: Eur Respir J 2005; 26: Suppl. 49, 312s
Year: 2005

New imaging techniques in the treatment guidelines for lung cancer
Source: Eur Respir J 2002; 19: 71S-83S
Year: 2002



Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002

Positron emission tomography in sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005

Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma
Source: Eur Respir J 2001; 18: Suppl. 33, 18s
Year: 2001